Issue 1263: August 31, 2016 Ask the Experts—Question of the Week: As I understand, the 4-day grace period for HPV vaccination can be applied to the…read more TOP STORIES
TOP STORIES
CDC publishes 2016–17 influenza vaccination recommendations
CDC published Prevention and Control of Seasonal Influenza with Vaccines Recommendations of the Advisory Committee on Immunization Practices—United States, 2016–17 Influenza Season in the August 26 Recommendations and Reports issue of MMWR (pages 1–54). A selection from the "Summary" section is reprinted below. Routine annual influenza vaccination is recommended for all persons aged ≥6 months who do not have contraindications. For the 2016–17 influenza season, inactivated influenza vaccines (IIVs) will be available in both trivalent (IIV3) and quadrivalent (IIV4) formulations. Recombinant influenza vaccine (RIV) will be available in a trivalent formulation (RIV3). In light of concerns regarding low effectiveness against influenza A(H1N1)pdm09 in the United States during the 2013–14 and 2015–16 seasons, for the 2016–17 season, ACIP makes the interim recommendation that live attenuated influenza vaccine (LAIV4) should not be used. Vaccine virus strains included in the 2016–17 U.S. trivalent influenza vaccines will be an A/California/7/2009 (H1N1)–like virus, an A/Hong Kong/4801/2014 (H3N2)-like virus, and a B/Brisbane/60/2008–like virus (Victoria lineage). Quadrivalent vaccines will include an additional influenza B virus strain, a B/Phuket/3073/2013-like virus (Yamagata lineage). Recommendations for use of different vaccine types and specific populations are discussed. A licensed, age-appropriate vaccine should be used. No preferential recommendation is made for one influenza vaccine product over another for persons for whom more than one licensed, recommended product is otherwise appropriate. Related Links
AAP releases new policy statement titled "Medical Versus Nonmedical Immunization Exemptions for Child Care and School Attendance," which urges states to eliminate all non-medical exemptions to vaccine requirements; related resources now available
The American Academy of Pediatrics (AAP) recently published a new policy statement, Medical Versus Nonmedical Immunization Exemptions for Child Care and School Attendance. The statement urges lawmakers to eliminate all non-medical exemptions for child care and school attendance. The abstract is reprinted below. Routine childhood immunizations against infectious diseases are an integral part of our public health infrastructure. They provide direct protection to the immunized individual and indirect protection to children and adults unable to be immunized via the effect of community immunity. All 50 states, the District of Columbia, and Puerto Rico have regulations requiring proof of immunization for child care and school attendance as a public health strategy to protect children in these settings and to secondarily serve as a mechanism to promote timely immunization of children by their caregivers. Although all states and the District of Columbia have mechanisms to exempt school attendees from specific immunization requirements for medical reasons, the majority also have a heterogeneous collection of regulations and laws that allow nonmedical exemptions from childhood immunizations otherwise required for child care and school attendance. The American Academy of Pediatrics (AAP) supports regulations and laws requiring certification of immunization to attend child care and school as a sound means of providing a safe environment for attendees and employees of these settings. The AAP also supports medically indicated exemptions to specific immunizations as determined for each individual child. The AAP views nonmedical exemptions to school-required immunizations as inappropriate for individual, public health, and ethical reasons and advocates for their elimination. To equip pediatricians with resources to approach vaccine-hesitant families, AAP additionally published a clinical report titled Countering Vaccine Hesitancy. A selection from the "Introduction" section is reprinted below. Immunizations have had an enormous impact on the health of children, and the prevention of disease by vaccination is one of the single greatest public health achievements of the last century. However, over the past decade acceptance of vaccines has been challenged by individuals and groups who question their benefit. Increasing numbers of people are requesting alternative vaccination schedules or postponing or declining vaccination. In a national telephone survey of 1500 parents of children 6 to 23 months of age conducted in 2010 with a response rate of 46%, approximately 3% of respondents had refused all vaccines and 19.4% had refused or delayed at least 1 of the recommended childhood vaccines. A study conducted in a metropolitan area of Oregon reported that rates of alternative immunization schedule usage have increased nearly fourfold in recent years, and in some parts of the country the use of “personal belief exemptions” from vaccinations has grown to rates in excess of 5% of the school-aged population. In conjunction with the policy statement and report, a free online course, Challenging Cases: Vaccine Hesitancy, is available through next year. Related Links
CDC reports on adolescent vaccination coverage rates in 2015
Today (Wednesday) is the last day of IAC's 20% off sale! The 20% discounts on record cards, schedules, DVDs, and books on Shop IAC end on Wednesday, August 31 IAC HANDOUTS
“Influenza Vaccine Products for the 2016–2017 Influenza Season” available with
updated information
IAC's Handouts for Patients & Staff web section offers healthcare professionals and the public more than 250 FREE English-language handouts (many also available in translation), which we encourage website users to print out, copy, and distribute widely. VACCINE INFORMATION STATEMENTS
Reminder! Influenza VIS for 2016–2017 influenza season is unchanged from the
2015–2016 version
WORLD NEWS CDC and WHO report on poliovirus vaccination campaign in India in MMWR and Weekly Epidemiological Report, respectively FEATURED RESOURCES CDC releases new labels for vaccines within storage units
As part of their storage and handling resources, CDC recently released new vaccine labels to help providers organize vaccines within their storage units. Vaccine Labels Examples and 2016–2017 Influenza Season Vaccine Label Examples are available for download now on CDC's website. The labels reflect ACIP guidelines and may include indications different from those of the Food and Drug Administration. Related Links
JOURNAL ARTICLES AND NEWSLETTERS Vaccine Education Center's newsletter for healthcare professionals includes updated Q&A information sheets for parents, a review of meningococcal B vaccine research, and the Technically Speaking column reviewing hepatitis B vaccine schedules and intervals
Additional resources, including information booklets for patients, are available in the full newsletter. EDUCATION AND TRAINING
Vaccine Education Center announces registration for September 21 webinar:
“FluMist: What went wrong?”
The Vaccine Education Center (VEC) at the Children's Hospital of Philadelphia, together with the Pennsylvania chapter of the American Academy of Pediatrics and supported by the Thomas F. McNair Scott Endowed Research and Lectureship Fund, will present a one-hour webinar, beginning at 12:00 p.m. (ET) on September 21. Part of its Current Issues in Vaccines series, the webinar will feature Paul Offit, MD, director of VEC. Dr. Offit's topic for this webinar will be: "FluMist: What went wrong?"
Free continuing education credits (CME, CEU, and CPE) will be available for both the live and archived events. Registration (required) is open now. Related Link
Weekly CDC webinar series on "The Pink Book" chapter topics continues through September 21; register now
Order Epidemiology and Prevention of Vaccine-Preventable Diseases
ASK THE EXPERTS
Question of the Week
|
About IZ Express
IZ Express is supported in part by Grant No. NH23IP922654 from CDC’s National Center for Immunization and Respiratory Diseases. Its contents are solely the responsibility of Immunize.org and do not necessarily represent the official views of CDC.
IZ Express Disclaimer
ISSN 2771-8085
IZ Express Disclaimer
ISSN 2771-8085
Editorial Information
-
Editor-in-ChiefKelly L. Moore, MD, MPH
-
Managing EditorJohn D. Grabenstein, RPh, PhD
-
Associate EditorSharon G. Humiston, MD, MPH
-
Writer/Publication CoordinatorTaryn Chapman, MS
Courtnay Londo, MA -
Style and Copy EditorMarian Deegan, JD
-
Web Edition ManagersArkady Shakhnovich
Jermaine Royes -
Contributing WriterLaurel H. Wood, MPA
-
Technical ReviewerKayla Ohlde